KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Common Equity (2021 - 2025)

Historic Common Equity for Crescent Capital BDC (CCAP) over the last 5 years, with Q3 2025 value amounting to $714.1 million.

  • Crescent Capital BDC's Common Equity fell 463.83% to $714.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $714.1 million, marking a year-over-year decrease of 463.83%. This contributed to the annual value of $740.6 million for FY2024, which is 26.35% down from last year.
  • According to the latest figures from Q3 2025, Crescent Capital BDC's Common Equity is $714.1 million, which was down 463.83% from $724.7 million recorded in Q2 2025.
  • In the past 5 years, Crescent Capital BDC's Common Equity registered a high of $752.4 million during Q2 2024, and its lowest value of $596.2 million during Q3 2021.
  • Moreover, its 5-year median value for Common Equity was $725.8 million (2023), whereas its average is $704.0 million.
  • In the last 5 years, Crescent Capital BDC's Common Equity tumbled by 609.3% in 2022 and then soared by 2123.17% in 2023.
  • Crescent Capital BDC's Common Equity (Quarter) stood at $652.3 million in 2021, then fell by 6.09% to $612.5 million in 2022, then increased by 21.23% to $742.6 million in 2023, then decreased by 0.26% to $740.6 million in 2024, then fell by 3.59% to $714.1 million in 2025.
  • Its Common Equity stands at $714.1 million for Q3 2025, versus $724.7 million for Q2 2025 and $727.1 million for Q1 2025.